H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol.

Ekoru K, Young EH, Adebamowo C, Balde N, Hennig BJ, Kaleebu P, Kapiga S, Levitt NS, Mayige M, Mbanya JC, McCarthy MI, Nyan O, Nyirenda M, Oli J, Ramaiya K, Smeeth L, Sobngwi E, Rotimi CN, Sandhu MS, Motala AA.

Glob Health Epidemiol Genom 2016;1:e5.

PMID:29276615

PMCID:PMC5732581

DOI:10.1017/gheg.2015.6

Related citation

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.

Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HE, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D.

BMC Public Health 2016;16:834.

Related citation

Sharing clinical trial data.
Hayes R, Ayles H, Binka F, Cowan F, Kamali A, Kapiga S, Kleinschmidt I, Mayaud P, Patel V, Smith P, Weiss H. Lancet 2016;387:2287.

DOI:https://doi.org/10.1016/S0140-6736(16)30682-1

Modest global achievements in maternal survival: more focus on sub-Saharan Africa is needed.

Holm Hansen C, Schellenberg JA.

The Lancet 2016;387:410-1

PMID:26869551

DOI:10.1016/S0140-6736(16)00099-4

Related citation

Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial.

Wandera B, Tumwesigye NM, Nankabirwa JI, Mafigiri DK, Parkes-Ratanshi RM, Kapiga S, Hahn J, Sethi AK.

J Int Assoc Provid AIDS Care. 2016; 16(3):276-285.

PMID:27215561

PMCID:PMC5121104

DOI:10.1177/2325957416649669

Related citation

The association between cervical human papillomavirus infection and subsequent HIV acquisition in Tanzanian and Ugandan women: a nested case-control study.

Gallagher KE, Baisley K, Grosskurth H, Vallely A, Kapiga S, Vandepitte J, Kamali A, De Sanjosé S, Changalucha J, Hayes R, Watson-Jones D.

J Infect Dis 2016;214:87-95.

PMID:26951818

PMCID:PMC4907415

DOI:10.1093/infdis/jiw094

Related citation

The incidence of human papillomavirus in Tanzanian adolescent girls before reported sexual debut.

Houlihan CF, Baisley K, Bravo I, Kapiga S, de Sanjose S, Changalucha J, Ross DA, Hayes R, Watson-Jones D.

J Adolesc Health 2016;58:295-301.

PMID:26725717

PMCID:PMC4762460

DOI:10.1016/j.jadohealth.2015.10.248

Related citation

The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring.

Hargreaves JR, Delany-Moretlwe S, Hallett TB, Johnson S, Kapiga S, Bhattacharjee P, Dallabetta G, Garnett GP.

Lancet HIV 2016;3(7):e318-22.

PMID:27365206

DOI:10.1016/S2352-3018(16)30063-7

Related citation

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

Howard N, Mounier-Jack S, Gallagher KE, Kabakama S, Griffiths UK, Feletto M, LaMontagne DS, Burchett HE, Watson-Jones D.

Hum Vaccin Immunother 2016;12:2475-7.

PMID:27159786

PMCID:PMC5027708

DOI:10.1080/21645515.2016.1178433

Related citation

Factors influencing completion of multidose vaccine schedules in adolescents: a systematic review.

Gallagher K, Kadokura E, Eckert, LO, Miyake S, Mounier Jack S, Aldea M, Ross D, Watson-Jones D.

BMC Public Health 2016;16(1):172.

PMID:26895838

PMCID:PMC4759915

DOI:10.1186/s12889-016-2845-z

Related citation